H.R. 5160 Passed the House Health

Stem Cell Therapeutic and Research Reauthorization Act of 2025

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

  1. Introduced
  2. Committee
  3. Passed House
  4. Passed Senate
  5. To President
  6. Became law
Sponsor Rep. Smith, Christopher H. [R-NJ-4] Introduced September 4, 2025 Cosponsors 21 (10 R, 11 D) Latest action July 21, 2026

Summary

Stem Cell Therapeutic and Research Reauthorization Act of 2025
This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).
The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research.
Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Summary by the Congressional Research Service, Library of Congress.

Congress.gov

Actions

  1. Jul 21, 2026 Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
  2. Jul 20, 2026 Motion to reconsider laid on the table Agreed to without objection.
  3. Jul 20, 2026 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
  4. Jul 20, 2026 DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
  5. Jul 20, 2026 Considered under suspension of the rules. (consideration: CR H4642-4643)
  6. Jul 20, 2026 Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
  7. Jul 2, 2026 Placed on the Union Calendar, Calendar No. 629.
  8. Jul 2, 2026 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
  9. May 21, 2026 Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
  10. May 21, 2026 Committee Consideration and Mark-up Session Held
  11. May 13, 2026 Forwarded by Subcommittee to Full Committee by Voice Vote.
  12. May 13, 2026 Subcommittee Consideration and Mark-up Session Held

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Search index and reflect what the press published, not 4Search's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.